Lantheus/LNTH

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Lantheus

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

Ticker

LNTH

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Bedford, United States

Employees

834

Lantheus Metrics

BasicAdvanced
$5.4B
Market cap
12.08
P/E ratio
$6.50
EPS
0.52
Beta
-
Dividend rate
$5.4B
0.52
4.843
4.451
66.16
66.238
30.96%
19.01%
66.21%
12.08
3.94
5.78
7.36
20.04
32.98%
-2,612.58%
58.77%
268.38%

What the Analysts think about Lantheus

Analyst Ratings

Majority rating from 11 analysts.
Buy

Lantheus Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
35.41% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$370M
4.52%
Net income
$131M
26.82%
Profit margin
35.41%
21.35%

Lantheus Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.48%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.54
$1.47
$1.75
$1.69
-
Expected
$1.31
$1.32
$1.45
$1.54
$1.82
Surprise
17.52%
11.12%
20.42%
9.48%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Lantheus stock?

Lantheus (LNTH) has a market cap of $5.4B as of July 04, 2024.

What is the P/E ratio for Lantheus stock?

The price to earnings (P/E) ratio for Lantheus (LNTH) stock is 12.08 as of July 04, 2024.

Does Lantheus stock pay dividends?

No, Lantheus (LNTH) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Lantheus dividend payment date?

Lantheus (LNTH) stock does not pay dividends to its shareholders.

What is the beta indicator for Lantheus?

Lantheus (LNTH) has a beta rating of 0.52. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Lantheus stock

Buy or sell Lantheus stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing